A protein linked to ALS and dementia, TDP43, plays a crucial role in regulating DNA mismatch repair, a process vital for maintaining genetic integrity and cellular health. This discovery, published in Nucleic Acids Research, could significantly impact our understanding of cancer and neurodegeneration. The study reveals that TDP43 regulates genes responsible for fixing DNA errors. When this protein is absent or overproduced, these repair genes become hyperactive, causing damage to neurons and genome instability, potentially leading to cancer. According to lead investigator Muralidhar L. Hegde, Ph.D., TDP43 is not merely an RNA-binding protein involved in splicing but a key regulator of the mismatch repair machinery, with significant implications for diseases like ALS and frontotemporal dementia (FTD). The research team also uncovered a connection between TDP43 and cancer. Analysis of extensive cancer datasets showed that high levels of TDP43 correlate with increased mutation rates, placing it at the intersection of neurodegeneration and cancer, two of the most pressing health concerns of our time. This finding opens up new avenues for treatment. By reducing overactive DNA repair in lab models, researchers partially reversed damage caused by TDP43 issues, suggesting that controlling DNA mismatch repair could be a therapeutic strategy. Collaborators on the study included Vincent Provasek, Suganya Rangaswamy, Manohar Kodavati, Joy Mitra, Vikas Malojirao, Velmarini Vasquez, Gavin Britz, and Sankar Mitra from Houston Methodist, Albino Bacolla and John Tainer from MD Anderson Cancer Center, Issa Yusuf and Zuoshang Xu from the University of Massachusetts, Guo-Min Li from UT Southwestern Medical Center, and Ralph Garruto from Binghamton University. The research was primarily supported by the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Aging of the National Institutes of Health (NIH), the Sherman Foundation Parkinson's Disease Research Challenge Fund, and internal funding from the Houston Methodist Research Institute. This groundbreaking discovery paves the way for novel treatments, offering hope for those affected by these devastating conditions.
